Damien JOLLY
Reims, France
NCT Number: NCT05392062
The pathophysiology of SARS-COV-2 related respiratory disease is still poorly understood, especially in its most severe form called acute respiratory distress syndrome (ARDS). In this case, very few studies have investigated changes in gas exchange during COVID-19 progression in spontaneously breathing patients. The investigators purpose in this study to explore the pathophysiology of gas exchange and time course changes in spontaneously breathing patients with acute respiratory failure due to COVID-19. Moreover, our aim is to identify early markers associated with worsening respiratory failure and requiring endotracheal intubation.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Reims, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Exploration of pathophysiology of gas exchange
Time frame: Lenght of hospital stay in intensive care unit
From date of admission in intensive care unit (ICU) until the date of death or disharge from ICU, assessed up to 90 days
Time frame: Day 90
No provided
Time frame: Day 28
No provided
Time frame: At admission
No provided
CHU de Reims
Other
Acronym: COVAQ
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04510662
COVID-19, Coronaviridae Infections
Zumpango, State of Mexico, Mexico
View Trial DetailsNCT04395144
ARDS, COVID
Gaspé, Quebec, Canada
View Trial DetailsNCT05508724
Lung Diseases, Respiration Disorders
Reading, United Kingdom
View Trial DetailsNCT03225807
ARDS, Acute Respiratory Distress Syndrome
Murray, Utah, United States
View Trial Details